BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6371644)

  • 1. Lonidamine, a new approach to cancer therapy.
    Caputo A; Silvestrini B
    Oncology; 1984; 41 Suppl 1():2-6. PubMed ID: 6371644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lonidamine alone or combined with hyperthermia in some experimental cell and tumour systems.
    Silvestrini B; Hahn GM; Cioli V; De Martino C
    Br J Cancer; 1983 Feb; 47(2):221-31. PubMed ID: 6824568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of tumor cell sensitivity to antineoplastic agents lonidamine and bouvardin (NSC 259968) at elevated temperatures.
    Adwankar MK; Chitnis MP
    Neoplasma; 1986; 33(2):217-23. PubMed ID: 3713924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells.
    Floridi A; Paggi MG; D'Atri S; De Martino C; Marcante ML; Silvestrini B; Caputo A
    Cancer Res; 1981 Nov; 41(11 Pt 1):4661-6. PubMed ID: 7306982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of the antitumor and antispermatogenic agent lonidamine on electron transport in Ehrlich ascites tumor mitochondria.
    Floridi A; Lehninger AL
    Arch Biochem Biophys; 1983 Oct; 226(1):73-83. PubMed ID: 6227286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory action of the antitumor agent lonidamine on mitochondrial respiration of Trypanosoma cruzi and T. brucei.
    Turrens JF
    Mol Biochem Parasitol; 1986 Sep; 20(3):237-41. PubMed ID: 3531848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of gossypol and Lonidamine on electron transport in Ehrlich ascites tumor mitochondria.
    Floridi A; D'Atri S; Bellocci M; Marcante ML; Paggi MG; Silvestrini B; Caputo A; De Martino C
    Exp Mol Pathol; 1984 Apr; 40(2):246-61. PubMed ID: 6705894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell membrane changes induced by lonidamine in human erythrocytes and T lymphocytes, and Ehrlich ascites tumor cells.
    De Martino C; Malorni W; Accinni L; Rosati F; Nista A; Formisano G; Silvestrini B; Arancia G
    Exp Mol Pathol; 1987 Feb; 46(1):15-30. PubMed ID: 3492392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells.
    Floridi A; Paggi MG; Marcante ML; Silvestrini B; Caputo A; De Martino C
    J Natl Cancer Inst; 1981 Mar; 66(3):497-9. PubMed ID: 6937706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological damage induced in vivo by Lonidamine on human metastatic cancer cells.
    De Martino C; Battelli T; Cavaliere R; Gallo Curcio C; Bellocci M; Manocchi D; Giustini L; Mattioli R; Rinaldi M; Di Filippo F
    Oncology; 1984; 41 Suppl 1():94-103. PubMed ID: 6717904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of adriamycin cytotoxicity in P388 murine leukemia sensitive and resistant to adriamycin by use of lonidamine and hyperthermia.
    Chitnis M; Adwankar M
    Tumori; 1986 Oct; 72(5):469-73. PubMed ID: 3798566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I toxicologic study of Lonidamine in cancer patients.
    Band PR; Deschamps M; Besner JG; Leclaire R; Gervais P; De Sanctis A
    Oncology; 1984; 41 Suppl 1():56-9. PubMed ID: 6717896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lonidamine: a hyperthermic sensitizer of HeLa cells in culture and of the Meth-A tumor in vivo.
    Kim JH; Kim SH; Alfieri A; Young CW; Silvestrini B
    Oncology; 1984; 41 Suppl 1():30-5. PubMed ID: 6717892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Lonidamine on murine and human tumor cells in vitro. A morphological and biochemical study.
    De Martino C; Battelli T; Paggi MG; Nista A; Marcante ML; D'Atri S; Malorni W; Gallo M; Floridi A
    Oncology; 1984; 41 Suppl 1():15-29. PubMed ID: 6717891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antitumor evaluation of selected 5,6-disubstituted 1(2)H-indazole-4,7-diones.
    Conway GA; Loeffler LJ; Hall IH
    J Med Chem; 1983 Jun; 26(6):876-84. PubMed ID: 6854591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of lonidamine in inoperable non-small-cell lung cancer.
    Kokron O; Maca S; Scheiner W; De Gregorio M; Ciottoli GB
    Oncology; 1984; 41 Suppl 1():86-9. PubMed ID: 6717902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential antitumor agents, XIII. Indole derivatives related to lonidamine.
    Andreani A; Rambaldi M; Bonazzi D; Andreani F; Bossa R; Galatulas I
    Arch Pharm (Weinheim); 1984 Oct; 317(10):847-51. PubMed ID: 6517671
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of the association of Gossypol and Lonidamine on the energy metabolism of Ehrlich ascites tumor cells.
    Floridi A; D'Atri S; Menichini R; Marcante ML; Nista A; Silvestrini B; Caputo A; De Martino C
    Exp Mol Pathol; 1983 Jun; 38(3):322-35. PubMed ID: 6852206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lonidamine on the mitochondrial potential in situ in Ehrlich ascites tumor cells.
    Pulselli R; Amadio L; Fanciulli M; Floridi A
    Anticancer Res; 1996; 16(1):419-23. PubMed ID: 8615647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors.
    Di Cosimo S; Ferretti G; Papaldo P; Carlini P; Fabi A; Cognetti F
    Drugs Today (Barc); 2003 Mar; 39(3):157-74. PubMed ID: 12730701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.